Treeline Biosciences
3 known investors
Treeline develops therapeutics focused on oncology, leveraging insights from clinical practice and laboratory research. The company serves cancer patients through drug discovery and development.
AI & Machine LearningBiotechMedical Devices
Founders & leadership
J
Jeff
Investors · 3
In the news
- Neumora's Phase 3 Trial Miss and a Trio of VC Raises — Watertown Biowatertown.bio · 2026
- Treeline Raises $200M in Additional Fundingfinsmes.com · 2025
- Treeline reaps $200M series A extension, plucks first 3 clinical candidatesfiercebiotech.com · 2025
- Startup Treeline Bio Emerges From the Shadows With $1B+ Raised and 3 Cancer Drugs in the Clinic - MedCity Newsmedcitynews.com · 2025
- Treeline Biosciences: $200 Million Additional Funding Raised And First Clinical Trials Announcedpulse2.com · 2025
- Treeline Biosciences raises $200M, enters clinical trials - Boston Business Journalbizjournals.com · 2025